Molecular investigation of Toxocara infection from the serum of people living with HIV in Alborz, Iran

BMC Infectious Diseases

Table 2 Demographic, immunologic, and clinical manifestation of seropositive patients (N = 10)

Patient number	Age	Sex	Cut-off point^* (NTU)	CD4⁺ Count (cells/µL)	Clinical signs
# 10	45	F	19.0	486	Asymptomatic
# 23	54	M	40.5	113	cerebral palsy, Diarrhea^**
# 28	46	M	16.9	472	Asymptomatic
# 32	28	F	21.2	190	Renal Failure, Diarrhea ^**
# 36	37	M	11.5	812	Bronchopneumonia
# 39	27	M	11.7	460	Asymptomatic
# 43	60	M	24.8	142	Type 1 diabetes^**
# 45	33	M	12.5	394	Hepatitis C
# 47	38	F	12.0	246	Epilepsy^**
# 53	45	F	23.5	187	Tuberculosis, Thyroid cancer
# 56	48	M	18.5	365	Cardiovascular disease
# 100	40	M	12.7	495	Asymptomatic

^*Cut- off point in ELISA: positive ˃ 11.0 NTU; NTU: NovaTec Unit; ^**Significant results at 95% confidence intervals (p ˂ 0.05) in HIV/AIDS patients with underlying conditions

ISSN: 1471-2334